Less Macular Pigment Linked to Disability Glare in Glaucoma Less Macular Pigment Linked to Disability Glare in Glaucoma

Lower macular pigment optical density (MPOD) is associated with glare-associated visual function and central visual field loss in patients with open-angle glaucoma, researchers report.Reuters Health Information
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Source Type: news

Related Links:

Authors: Serin-Brackman V, Pezet Poux J, Quintyn JC Abstract INTRODUCTION: Balance is an active system allowing the body to maintain individual stability despite external stimuli. It relies on many senses which provide data to compensate for external variations such as visual information. It is thus necessary that the senses be in good condition and transmit accurate data. We wished to study postural adaptations made by visually impaired people. MATERIAL AND METHODS: We performed a prospective study of patients with macular degeneration with visual acuity less than 20/40, glaucoma with a mean visual field defec...
Source: Journal Francais d Ophtalmologie - Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research
Conclusions: The QuickDASH survey may identify patients with eye drop administration difficulties so this population receives focused drop technique education and management strategies. PMID: 31157555 [PubMed - as supplied by publisher]
Source: Current Eye Research - Category: Opthalmology Authors: Tags: Curr Eye Res Source Type: research
Conclusion: Patients with isolated thalamic atrophy were at a higher risk for not reaching 2-year NEDA-3 and for EDSS increase than patients with no identified brain atrophy. The groups were clinically indistinguishable. A single measurement of thalamic and whole brain atrophy could help identify patients needing most effective therapies from early on. Introduction The quantification of brain atrophy by MRI has become an increasingly important part of evaluating neurodegeneration in MS (1, 2). Atrophy measures can reflect the damage on the central nervous system (CNS) caused by the pathological processes of the dis...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
The $768 billion Medicare program is in deep trouble as America ages and elderly health care soars in cost. Medicare is a giant central planning scheme that imposes more than 100,000 pages of regulations and related rules on more than 600,000 health care providers.   The inefficiency is vast, and the structure of the program makes it a perfect target for fraud and abuse. The system processes more than a billion provider claims a year. Auditorsestimate that more than $50 billion of taxpayer money goes down the drain every year from improper payments. TheNew York Timeshighlights some alleged scams today stemming fr...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
To the Editor We read the article “Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain: A Randomized Clinical Trial” by Urquhart and colleagues, in which the authors found a significant reduction in disability at 3 months following treatment with amitriptyline but not at 6 months. The other outcome parameters, such as p ain intensity and work absence and hindrance, were not significantly different between the amitriptyline and the control groups. Adverse effects of a drug are an important outcome measure. A drug may be effective but may not be used because of its severe adverse effects, such as reserpi...
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research
AbstractThe development of neuroprotective therapies is a sought-after goal. By screening combinatorial chemical libraries usingin vitro assays, we identified the small molecule BN201 that promotes the survival of cultured neural cells when subjected to oxidative stress or when deprived of trophic factors. Moreover, BN201 promotes neuronal differentiation, the differentiation of precursor cells to mature oligodendrocytesin vitro, and the myelination of new axons. BN201 modulates several kinases participating in the insulin growth factor 1 pathway including serum –glucocorticoid kinase and midkine, inducing the phosph...
Source: Neurotherapeutics - Category: Neurology Source Type: research
In clinical glaucoma research, the measurement of patient reported outcomes, functional assessment of disability, and health economic impact is critical. However, valid, time-efficient and comprehensive tools are not available and several current instruments lack in the appropriate precision for measuring the various dimensions of glaucoma-related quality of life (QoL), including functioning and mobility. Furthermore, statistical methods are inconsistently and sometimes incorrectly used in otherwise sound clinical studies. Standardizing and improving methods of patient-centered data collection and analysis in glaucoma stud...
Source: Journal of Glaucoma - Category: Opthalmology Tags: Perspective Source Type: research
Conclusion: Data from applications for blindness certificates provide valuable information regarding different causes of VI that might otherwise not be eligible for blindness certification and provide an insight into the overall trends in disease profile and service delivery.
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
This study determined the impact of visual disabilities caused by glaucoma on the patient's everyday life and emphasized the importance of developing strategies to improve reading ability in primary open-angle glaucoma (POAG) patients. PURPOSE The purposes of this study were to investigate the reading performances of patients affected by POAG using the Italian version of the Radner Reading Charts and to test the presence of correlation between visual field (VF) damage and reading parameters. METHODS In this cross-sectional observational study, all patients underwent a complete ophthalmic evaluation including VF testi...
Source: Optometry and Vision Science - Category: Opthalmology Tags: ORIGINAL INVESTIGATIONS Source Type: research
Easy-to-use, accessible and relatively low-cost solution for a widely experienced problem: these are my favorite digital health innovations. EyeQue Insight lets anyone test their vision at home so people living in rural areas, with special needs or no access to transportation could still make sure they have the necessary sight test from time to time. Here’s our EyeQue Insight review. Have you seen the numbers? What about the letters? Eye problems are global phenomena: the World Health Organisation estimates that approximately 1.3 billion people live with some form of vision impairment. That means on average at least ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Health Sensors & Trackers Medical Professionals Patients eye eye test future home Innovation ophthalmology review technology testing vision Source Type: blogs
More News: Disability | Glaucoma | Opthalmology